Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Department of Medical Statistics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Sci Rep. 2019 Dec 2;9(1):18055. doi: 10.1038/s41598-019-54528-w.
Although chronic kidney disease is known to increase the risk of atrial fibrillation (AF), the impact of the variability of renal function on the risk of incident AF is unknown. We aimed to evaluate the association between variability of renal function and the risk of developing AF among the general population. We evaluated a total of 3,551,249 adults who had three annual health check-ups provided by the National Health Insurance Service. The variability of renal function was defined as GFR-VIM, which is variability independent of the mean (VIM) of creatinine-based estimated glomerular filtration rate (eGFR). The study population was divided into four groups (Q1-4) based on the quartiles of GFR-VIM, and the risks of incident AF by each group were compared. During a mean of 3.2 ± 0.5 years follow-up, incident AF occurred in 15,008 (0.42%) subjects. The incidence rates of AF increased from Q1 to Q4 (0.98, 1.42, 1.27, and 1.63 per 1,000 person-years, respectively). Adjusting with multiple variables, Q4 showed an increased risk of incident AF compared to Q1 (hazard ratio (HR) 1.125, 95% confidence interval (CI) 1.071-1.181). Variability of serum creatinine or other definitions of variability showed consistent results. On subgroup analyses, Q4 in males or those with a decreasing trend of eGFR had significantly increased risks of incident AF compared to Q1 (HR 1.127, 95% CI 1.082-1.175; and HR 1.115, 95% CI 1.059-1.173, respectively). High variability of eGFR was associated with an increased risk of incident AF, particularly in males or those with decreasing trends of eGFR during follow-up.
尽管慢性肾脏病已知会增加心房颤动(AF)的风险,但肾功能变异性对 AF 发病风险的影响尚不清楚。我们旨在评估一般人群中肾功能变异性与发生 AF 风险之间的关系。我们评估了总共 3551249 名接受国民健康保险服务提供的三次年度健康检查的成年人。肾功能变异性定义为 GFR-VIM,即基于肌酐的估算肾小球滤过率(eGFR)的均值(VIM)的变异性独立。根据 GFR-VIM 的四分位数,将研究人群分为四组(Q1-4),并比较每组的新发 AF 风险。在平均 3.2±0.5 年的随访期间,15008 名(0.42%)患者发生新发 AF。AF 的发生率从 Q1 到 Q4 逐渐升高(0.98、1.42、1.27 和 1.63 每 1000 人年,分别)。调整多个变量后,与 Q1 相比,Q4 发生新发 AF 的风险增加(风险比(HR)1.125,95%置信区间(CI)1.071-1.181)。血清肌酐的变异性或其他变异性定义的结果一致。在亚组分析中,与 Q1 相比,男性或 eGFR 呈下降趋势的 Q4 患者新发 AF 的风险显著增加(HR 1.127,95%CI 1.082-1.175;和 HR 1.115,95%CI 1.059-1.173,分别)。eGFR 的高变异性与新发 AF 的风险增加相关,特别是在随访期间男性或 eGFR 呈下降趋势的患者。